Tomasz Wypych

Dr. Tomasz Wypych


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TWTomasz Wypych
Tomasz Wypych
LWLakshanie C. Wickramasinghe
Lakshanie C. Wickramasinghe
BMBenjamin J. Marsland
Benjamin J. Marsland

19 February 2021 in Mucosal Immunology
Verified
Journal Article
Closed access
PDF file
JDJordan D. Davis
Jordan D. Davis
TWTomasz Wypych
Tomasz Wypych

25 January 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TWTomasz Wypych
Tomasz Wypych
CPCéline Pattaroni
Céline Pattaroni
OPOlaf Perdijk
Olaf Perdijk
CYCarmen Yap
Carmen Yap
ATAurélien Trompette
Aurélien Trompette
BMBenjamin J. Marsland
Benjamin J. Marsland

16 July 2021 in Science Advances
Verified
Journal Article
Open access
AGAlejandra González-Loyola
Alejandra González-Loyola
EBEsther Bovay
Esther Bovay
JKJaeryung Kim
Jaeryung Kim
TLTania Wyss Lozano
Tania Wyss Lozano
ASAmélie Sabine
Amélie Sabine
TPTatiana V. Petrova
Tatiana V. Petrova
Foxc2sustains adult lymphatic vascular specialization and coordinates organ-specific lymph flow, gut microbiota, and inflammation.

5 July 2012 in Blood
Verified
Journal Article
Closed access
PDF file
JDJeroen den Dunnen
Jeroen den Dunnen
LVLisa T. C. Vogelpoel
Lisa T. C. Vogelpoel
TWTomasz Wypych
Tomasz Wypych
FMFemke J. M. Muller
Femke J. M. Muller
LBLeonie de Boer
Leonie de Boer
EJEsther C. de Jong
Esther C. de Jong
Dendritic cells (DCs) are essential in inducing adaptive immune responses against bacteria by expressing cytokines that skew T-cell responses toward protective Th17 cells. Although it is widely recognized that induction of these cytokines by DCs involves activation of multiple receptors, it is still incompletely characterized which combination of receptors specifically skews Th17-cell responses. Here we have identified a novel role for FcγRIIa in promoting human Th17 cells. Activation of DCs by bacteria opsonized by serum IgG strongly promoted Th17 responses, which was FcγRIIa-dependent and coincided with enhanced production of selected cytokines by DCs, including Th17-promoting IL-1β and IL-23. Notably, FcγRIIa stimulation on DCs did not induce cytokine production when stimulated individually, but selectively amplified cytokine responses through synergy with TLR2, 4, or 5. Importantly, this synergy is mediated at 2 different levels. First, TLR-FcγRIIa costimulation strongly increased transcription of pro-IL-1β and IL-23p19. Second, FcγRIIa triggering induced activation of caspase-1, which cleaves pro-IL-1β into its bioactive form and thereby enhanced IL-1β secretion. Taken together, these data identified cross-talk between TLRs and FcγRIIa as a novel mechanism by which DCs promote protective effector Th17-cell responses against bacteria.

15 July 2024 in Immunity
Verified
Journal Article
Closed access
OPOlaf Perdijk
Olaf Perdijk
ABAlana Butler
Alana Butler
MMMatthew Macowan
Matthew Macowan
RCRoxanne Chatzis
Roxanne Chatzis
EBEdyta Bulanda
Edyta Bulanda
BMBenjamin J. Marsland
Benjamin J. Marsland